FDA NDC Directory · JSON-LD · Markdown

NICORETTE

NDC 0135-0625 · HUMAN OTC DRUG · LOZENGE

Generic namenicotine polacrilex
Labeler / ManufacturerHaleon US Holdings LLC
Marketing categoryNew Drug Application (innovator) · App NDA021330
Dosage form / routeLOZENGE · ORAL
Active ingredientsNICOTINE (2 mg/1)
Marketing started20190411
Package count3

External sources

Source: openFDA. Public-domain (CC0).